Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort studyMichela Botta, Liselotte Hol, Alexander P. J. Vlaar et al.|The Lancet Respiratory Medicine|2020Cited by 306
Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID studyJan-Paul Roozeman, Guido Mazzinari, Ary Serpa Neto et al.|Journal of Critical Care|2021Cited by 22
Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients — insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysisSanchit Ahuja, Janneke Horn, Harm‐Jan de Grooth et al.|Critical Care|2022Cited by 21
Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID studyM.T.U. Schuijt, Eline Kho, Ignacio Martín‐Loeches et al.|Journal of Critical Care|2021Cited by 12
High PEEP/low FiO2 ventilation is associated with lower mortality in COVID–19Robin L. Goossen, Dave A. Dongelmans, Relin van Vliet et al.|Journal of Critical Care|2024Cited by 3